Showing results (281-290 of 447) with videos related to
Sort By:
Pageof 45
Molecular Cell|May 27, 2023
IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistanceYi Han, Yan-Yu Zhang, Yi-Qian Pan, et al.Cell Death & Disease|October 28, 2016
Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathwayYun-Xin Lu, Dong-Liang Chen, De-Shen Wang, et al.Signal Transduction and Targeted Therapy|February 28, 2022
Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosisJin-Fei Lin, Pei-Shan Hu, Yi-Yu Wang, et al.Oncogene|July 7, 2022
Arginine methylation of MTHFD1 by PRMT5 enhances anoikis resistance and cancer metastasisQi Meng, Yun-Xin Lu, Chen Wei, et al.Stem Cells (Dayton, Ohio)|November 10, 2017
Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b AxisHai-Yan Bai, Yi-Ji Liao, Mu-Yan Cai, et al.World Journal of Gastroenterology|January 7, 2015
Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancerXiao-Li Wei, De-Shen Wang, Shao-Yan Xi, et al.Future Oncology (London, England)|February 10, 2021
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in the FRESCO trialShukui Qin, Jin Li, Yuxian Bai, et al.Nature Communications|November 17, 2022
First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumorsXiao-Li Wei, Fu-Rong Liu, Ji-Hong Liu, et al.Advances in Therapy|November 18, 2025
Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-upMarcia Cruz-Correa, Do-Youn Oh, Ken Kato, et al.Cell Death & Disease|May 30, 2019
Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancerHong-En Yu, Feng Wang, Fang Yu, et al.Pageof 45